61Cu-NODAGA-LM3 + Comparator for neuroendocrine tumors

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Jun 2024: Trial registered, NCT06455358
  2. 5 Feb 2025: Trial started, NCT06455358

The trials

NCT06455358: 61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET)

State
Under way
Phase
Phase 1 and Phase 2
People
27 planned
Started
5 Feb 2025
Primary completion
Jun 2028
Arms
61Cu-NODAGA-LM3 PET/CT before 68Ga-DOTATOC PET/CT, 61Cu-NODAGA-LM3 PET/CT after 68Ga-DOTATOC PET/CT
Results
None posted
  1. 12 Jun 2024: Trial registered
  2. 5 Feb 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.